Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.
Kolenda T, Rutkowski P, Michalak M, Kozak K, Guglas K, Ryś M, Galus Ł, Woźniak S, Ługowska I, Gos A, Teresiak A, Mackiewicz A, Lamperska K, Mackiewicz J.
Kolenda T, et al. Among authors: mackiewicz a, mackiewicz j.
Oncotarget. 2019 Jun 11;10(39):3879-3893. doi: 10.18632/oncotarget.26989. eCollection 2019 Jun 11.
Oncotarget. 2019.
PMID: 31231466
Free PMC article.